Our President & CEO, Mr. Sato, will participate in the 2nd Asian Drug Delivery & Formulation Summit in Singapore.
On November 21 at 15:55 local time, he will deliver a presentation titled:
“Advancements in Antisense Oligonucleotide Therapeutics: Targeting Neurological Diseases with Novel Modified Nucleic Acids Technologies.”
We are looking forward to seeing you.
Click here for more details.